![](/img/cover-not-exists.png)
MErCuRIC1: A phase 1a study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in patients with advanced solid tumours
Wilson, R., Middleton, M.R., Houlden, J., Van Schaeybroeck, S., Rolfo, C.D., Elez, E., Taieb, J., André, T., Bardelli, A., Laurent-Puig, P., Tabernero, J., Peeters, M., Maughan, T., Roberts, C., Love,Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw370.28
Date:
October, 2016
File:
PDF, 43 KB
english, 2016